LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 52 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $5,414,000 | -58.2% | 5,437 | -56.3% | 0.50% | -60.5% |
| Q1 2021 | $12,966,000 | +265.2% | 12,437 | +232.3% | 1.27% | +161.5% |
| Q4 2020 | $3,550,000 | +5.2% | 3,743 | -99.9% | 0.49% | -33.8% |
| Q3 2020 | $3,376,000 | -39.4% | 3,743,000 | -41.1% | 0.73% | -66.1% |
| Q2 2020 | $5,569,000 | +183.0% | 6,350,000 | +170.2% | 2.17% | +93.9% |
| Q1 2020 | $1,968,000 | -3.0% | 2,350,000 | 0.0% | 1.12% | +9.9% |
| Q4 2019 | $2,028,000 | -54.5% | 2,350,000 | -56.1% | 1.02% | -59.8% |
| Q3 2019 | $4,459,000 | +281.4% | 5,350,000 | +296.3% | 2.53% | +272.7% |
| Q2 2019 | $1,169,000 | – | 1,350,000 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 64,118,000 | $55,709,000 | 4.91% |
| SYMPHONY ASSET MANAGEMENT LLC | 9,000,000 | $7,790,000 | 1.72% |
| CANYON CAPITAL ADVISORS LLC | 65,000,000 | $56,160,000 | 1.31% |
| CAMDEN ASSET MANAGEMENT L P /CA | 44,450,000 | $38,362,000 | 1.24% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 60,954,000 | $52,832,000 | 1.02% |
| Context Capital Management, LLC | 2,350,000 | $2,028,000 | 1.02% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,160,000 | $3,622,000 | 0.47% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 22,500,000 | $19,418,000 | 0.44% |
| OAKTREE CAPITAL MANAGEMENT LP | 23,903,000 | $20,688,000 | 0.39% |
| WOLVERINE ASSET MANAGEMENT LLC | 36,633,000 | $31,784,000 | 0.37% |